Protein FAM90A20 (FAM90A20)
Homo sapiens — UniProt A6NIJ5
Data last refreshed: (UniProt release unknown)
Key facts
Protein FAM90A20 (FAM90A20) is a protein from Homo sapiens identified by UniProt accession A6NIJ5, 464 residues long. MolForge cross-references it against 0 known binders and 1 disease associations.
- UniProt accession: A6NIJ5; gene symbol FAM90A20.
- Organism: Homo sapiens.
- Length: 464 amino acids.
- Top disease associations (Open Targets): hypertrophic cardiomyopathy.
- 3D structure: AlphaFold model available.
Target properties
| Protein name | Protein FAM90A20 |
|---|---|
| UniProt accession | A6NIJ5 |
| Gene | FAM90A20 |
| Organism | Homo sapiens |
| Length | 464 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | — |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
|---|---|
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (1)
Diseases linked to this target (Open Targets).
- hypertrophic cardiomyopathy · score 0.00
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
|---|---|---|---|---|
| AF-A6NIJ5-F1 | alphafold | PREDICTED | 50.40 | — |
Experimental structures are not indexed in MolForge yet — search RCSB PDB for A6NIJ5.
Amino-acid sequence (464 residues)
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
Which diseases are associated with FAM90A20?
The strongest Open Targets associations for FAM90A20 are hypertrophic cardiomyopathy.
How long is the FAM90A20 protein?
The Homo sapiens FAM90A20 protein (UniProt A6NIJ5) is 464 amino acids long.
Browse: Targets: F · all protein targets A–Z · drugs A–Z.
Sources
- UniProtKB A6NIJ5 — name, gene, function, sequence, keywords (CC BY 4.0)
- AlphaFold DB A6NIJ5 — predicted 3D structure (CC BY 4.0)
- Open Targets Platform — disease associations and tractability (CC0)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.